Travere Therapeutics
TVTX
#4650
Rank
NZ$2.61 B
Marketcap
$29.45
Share price
5.57%
Change (1 day)
220.79%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2023 (TTM): -$7.41

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.55. In 2022 the company made an earnings per share (EPS) of -$7.30 a decrease over its 2021 EPS that were of -$5.06.

EPS history for Travere Therapeutics from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.411.48%
2022-$7.3044.22%
2021-$5.06-10.09%
2020-$5.63-2.6%
2019-$5.7836.22%
2018-$4.2464.94%
2017-$2.5720.31%
2016-$2.14-135.46%
2015$6.03-175.68%
2014-$7.9798.75%
2013-$4.011746.15%
2012-$0.221.34%
2011-$0.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.67-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.45-94.03%๐Ÿ‡บ๐Ÿ‡ธ USA